14th Biologics Manufacturing Asia 2027 is a conference dedicated to the challenges faced in the Asian biologics manufacturing sector.
Key Topics
Incorporating QbD in the early process development.
Reducing the timelines and need for efficient screening technologies and monitoring bioprocesses in order to reduce timelines for upstream bioprocesses.
Development of robust processes to suit evolving biomanufacturing needs.
Technical and economic viability of using a single-use biomanufacturing facility.
Optimization of downstream purification for highly complex molecules.
Purification process development to maximize process economy.
Designing and automating quality control during scale-up and process change.
